Anti-fibrillarin antibody in African American patients with systemic sclerosis: Immunogenetics, clinical features, and survival analysis (The Journal of Rheumatology (2011))

S. Sharif, M. J. Fritzler, M. D. Mayes, E. B. Gonzalez, T. A. McNearney, H. Draeger, M. Baron, D. E. Furst, D. K. Khanna, D. J. Del Junco, J. A. Molitor, E. Schiopu, K. Phillips, J. R. Seibold, R. M. Silver, R. W. Simms, M. Perry, C. Rojo, J. Charles, X. ZhouS. K. Agarwal, J. D. Reveille, S. Assassi, F. C. Arnett

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Number of pages1
JournalJournal of Rheumatology
Volume38
Issue number7
DOIs
StatePublished - Jul 1 2011

Cite this

Sharif, S., Fritzler, M. J., Mayes, M. D., Gonzalez, E. B., McNearney, T. A., Draeger, H., Baron, M., Furst, D. E., Khanna, D. K., Del Junco, D. J., Molitor, J. A., Schiopu, E., Phillips, K., Seibold, J. R., Silver, R. M., Simms, R. W., Perry, M., Rojo, C., Charles, J., ... Arnett, F. C. (2011). Anti-fibrillarin antibody in African American patients with systemic sclerosis: Immunogenetics, clinical features, and survival analysis (The Journal of Rheumatology (2011)). Journal of Rheumatology, 38(7). https://doi.org/10.3899/jrheum.110071C1